Advertisement
JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Originally published In Press as doi:10.1074/jbc.M102453200 on May 25, 2001

J. Biol. Chem., Vol. 276, Issue 30, 27846-27854, July 27, 2001
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
276/30/27846    most recent
M102453200v1
Right arrow Submit a Letter to Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Leslie, E. M.
Right arrow Articles by Cole, S. P. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Leslie, E. M.
Right arrow Articles by Cole, S. P. C.
Social Bookmarking
Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Transport of the beta -O-Glucuronide Conjugate of the Tobacco-specific Carcinogen 4-(Methylnitrosamino)-1-(3-pyridyl)-1-butanol (NNAL) by the Multidrug Resistance Protein 1 (MRP1)
REQUIREMENT FOR GLUTATHIONE OR A NON-SULFUR-CONTAINING ANALOG*

Elaine M. LeslieDagger §, Ken-ichi Ito§, Pramod Upadhyaya||, Stephen S. Hecht||, Roger G. Deeley§, and Susan P. C. ColeDagger §**

From the Dagger  Department of Pharmacology & Toxicology and the § Cancer Research Laboratories, Queen's University, Kingston, Ontario, K7L 3N6 Canada and the || University of Minnesota Cancer Center, Minneapolis, Minnesota 55455

Nitrosamine 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) and its metabolite 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol (NNAL) play a crucial role in the induction of lung cancer, and NNAL-O-glucuronide formation and elimination are important steps in detoxification of these compounds. In the present study, we investigated the ATP-binding cassette (ABC) protein, MRP1 (ABCC1), as a candidate transporter responsible for NNAL-O-glucuronide export. MRP1 mediates the active transport of numerous GSH-, sulfate-, and glucuronide-conjugated organic anions and can transport certain xenobiotics by a mechanism that may involve co-transport with GSH. Using membrane vesicles prepared from transfected cells, we found that MRP1 transports [3H]NNAL-O-glucuronide but is dependent on the presence of GSH (Km 39 µM, Vmax 48 pmol mg-1 min-1). We also found that the sulfur atom in GSH was dispensable because transport was supported by the GSH analog, gamma -glutamyl-alpha -aminobutyryl-glycine. Despite stimulation of NNAL-O-glucuronide transport by GSH, there was no detectable reciprocal stimulation of [3H]GSH transport. Moreover, whereas the MRP1 substrates leukotriene C4 (LTC4) and 17beta -estradiol 17beta -(D-glucuronide) (E217beta G) inhibited GSH-dependent uptake of [3H]NNAL-O-glucuronide, only [3H]LTC4 transport was inhibited by NNAL-O-glucuronide (+GSH) and the kinetics of inhibition were complex. A mutant form of MRP1, which transports LTC4 but not E217beta G, also did not transport NNAL-O-glucuronide suggesting a commonality in the binding elements for these two glucuronidated substrates, despite their lack of reciprocal transport inhibition. Finally, the related MRP2 transported NNAL-O-glucuronide with higher efficiency than MRP1 and unexpectedly, GSH inhibited rather than stimulated uptake. These studies provide further insight into the complex interactions of the MRP-related proteins with GSH and their conjugated organic anion substrates, and extend the range of xenotoxins transported by MRP1 and MRP2 to include metabolites of known carcinogens involved in the etiology of lung and other cancers.

* This work was supported by Grant MT-10519 from the Medical Research Council of Canada (MRCC)/Canadian Institutes of Health Research (CIHR) and Grant no. CA-81301 from the National Institutes of Health.The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

Recipient of an MRCC Doctoral Award.

** Senior Scientist of Cancer Care Ontario. To whom correspondence should be addressed: Cancer Research Laboratories, Rm. 328, Botterell Hall, Queen's University, Kingston, Ontario, K7L 3N6 Canada. Tel.: 613-533-2636; Fax: 613-533-6830; E-mail: coles@post.queensu.ca.

Copyright © 2001 by The American Society for Biochemistry and Molecular Biology, Inc.
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
 Drug Metab. Dispos.Home page
K. Maeno, A. Nakajima, G. Conseil, A. Rothnie, R. G. Deeley, and S. P. C. Cole
Molecular Basis for Reduced Estrone Sulfate Transport and Altered Modulator Sensitivity of Transmembrane Helix (TM) 6 and TM17 Mutants of Multidrug Resistance Protein 1 (ABCC1)
Drug Metab. Dispos., July 1, 2009; 37(7): 1411 - 1420.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Pharmacol.Home page
A. Rothnie, G. Conseil, A. Y. T. Lau, R. G. Deeley, and S. P. C. Cole
Mechanistic Differences between GSH Transport by Multidrug Resistance Protein 1 (MRP1/ABCC1) and GSH Modulation of MRP1-Mediated Transport
Mol. Pharmacol., December 1, 2008; 74(6): 1630 - 1640.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Pharmacol.Home page
A. A. K. El-Sheikh, J. J. M. W. van den Heuvel, E. Krieger, F. G. M. Russel, and J. B. Koenderink
Functional Role of Arginine 375 in Transmembrane Helix 6 of Multidrug Resistance Protein 4 (MRP4/ABCC4)
Mol. Pharmacol., October 1, 2008; 74(4): 964 - 971.
[Abstract] [Full Text] [PDF]

Home page
 CarcinogenesisHome page
E. M. Leslie, G. Ghibellini, K.-i. Nezasa, and K. L.R. Brouwer
Biotransformation and transport of the tobacco-specific carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) in bile duct-cannulated wild-type and Mrp2/Abcc2-deficient (TR ) Wistar rats
Carcinogenesis, December 1, 2007; 28(12): 2650 - 2656.
[Abstract] [Full Text] [PDF]

Home page
 Physiol. Rev.Home page
R. G. Deeley, C. Westlake, and S. P. C. Cole
Transmembrane Transport of Endo- and Xenobiotics by Mammalian ATP-Binding Cassette Multidrug Resistance Proteins.
Physiol Rev, July 1, 2006; 86(3): 849 - 899.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
T. Soga, R. Baran, M. Suematsu, Y. Ueno, S. Ikeda, T. Sakurakawa, Y. Kakazu, T. Ishikawa, M. Robert, T. Nishioka, et al.
Differential Metabolomics Reveals Ophthalmic Acid as an Oxidative Stress Biomarker Indicating Hepatic Glutathione Consumption
J. Biol. Chem., June 16, 2006; 281(24): 16768 - 16776.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
A. Rothnie, R. Callaghan, R. G. Deeley, and S. P. C. Cole
Role of GSH in Estrone Sulfate Binding and Translocation by the Multidrug Resistance Protein 1 (MRP1/ABCC1)
J. Biol. Chem., May 19, 2006; 281(20): 13906 - 13914.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Pharmacol.Home page
C. S. Morrow, C. Peklak-Scott, B. Bishwokarma, T. E. Kute, P. K. Smitherman, and A. J. Townsend
Multidrug Resistance Protein 1 (MRP1, ABCC1) Mediates Resistance to Mitoxantrone via Glutathione-Dependent Drug Efflux
Mol. Pharmacol., April 1, 2006; 69(4): 1499 - 1505.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Biol. CellHome page
C. J. Westlake, S. P.C. Cole, and R. G. Deeley
Role of the NH2-terminal Membrane Spanning Domain of Multidrug Resistance Protein 1/ABCC1 in Protein Processing and Trafficking
Mol. Biol. Cell, May 1, 2005; 16(5): 2483 - 2492.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
X.-Q. Ren, T. Furukawa, Y. Nakajima, H. Takahashi, S. Aoki, T. Sumizawa, M. Haraguchi, M. Kobayashi, K. Chijiiwa, and S.-i. Akiyama
GSH Inhibits Trypsinization of the C-terminal Half of Human MRP1
J. Biol. Chem., February 18, 2005; 280(7): 6231 - 6237.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Pharmacol.Home page
Z.-S. Chen, Y. Guo, M. G. Belinsky, E. Kotova, and G. D. Kruh
Transport of Bile Acids, Sulfated Steroids, Estradiol 17-{beta}-D-Glucuronide, and Leukotriene C4 by Human Multidrug Resistance Protein 8 (ABCC11)
Mol. Pharmacol., February 1, 2005; 67(2): 545 - 557.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
C. J. Westlake, L. Payen, M. Gao, S. P. C. Cole, and R. G. Deeley
Identification and Characterization of Functionally Important Elements in the Multidrug Resistance Protein 1 COOH-terminal Region
J. Biol. Chem., December 17, 2004; 279(51): 53571 - 53583.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
D. Situ, A. Haimeur, G. Conseil, K. E. Sparks, D. Zhang, R. G. Deeley, and S. P. C. Cole
Mutational Analysis of Ionizable Residues Proximal to the Cytoplasmic Interface of Membrane Spanning Domain 3 of the Multidrug Resistance Protein, MRP1 (ABCC1): GLUTAMATE 1204 IS IMPORTANT FOR BOTH THE EXPRESSION AND CATALYTIC ACTIVITY OF THE TRANSPORTER
J. Biol. Chem., September 10, 2004; 279(37): 38871 - 38880.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
E. M. Leslie, A. Haimeur, and M. P. Waalkes
Arsenic Transport by the Human Multidrug Resistance Protein 1 (MRP1/ABCC1): EVIDENCE THAT A TRI-GLUTATHIONE CONJUGATE IS REQUIRED
J. Biol. Chem., July 30, 2004; 279(31): 32700 - 32708.
[Abstract] [Full Text] [PDF]

Home page
 CarcinogenesisHome page
C. L. Zimmerman, Z. Wu, P. Upadhyaya, and S. S. Hecht
Stereoselective metabolism and tissue retention in rats of the individual enantiomers of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol (NNAL), metabolites of the tobacco-specific nitrosamine, 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK)
Carcinogenesis, July 1, 2004; 25(7): 1237 - 1242.
[Abstract] [Full Text] [PDF]

Home page
 J. Pharmacol. Exp. Ther.Home page
X.-Y. Chu, S.-E. W. Huskey, M. P. Braun, B. Sarkadi, D. C. Evans, and R. Evers
Transport of Ethinylestradiol Glucuronide and Ethinylestradiol Sulfate by the Multidrug Resistance Proteins MRP1, MRP2, and MRP3
J. Pharmacol. Exp. Ther., April 1, 2004; 309(1): 156 - 164.
[Abstract] [Full Text]

Home page
 J. Biol. Chem.Home page
K. Koike, G. Conseil, E. M. Leslie, R. G. Deeley, and S. P. C. Cole
Identification of Proline Residues in the Core Cytoplasmic and Transmembrane Regions of Multidrug Resistance Protein 1 (MRP1/ABCC1) Important for Transport Function, Substrate Specificity, and Nucleotide Interactions
J. Biol. Chem., March 26, 2004; 279(13): 12325 - 12336.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
D.-W. Zhang, H.-M. Gu, D. Situ, A. Haimeur, S. P. C. Cole, and R. G. Deeley
Functional Importance of Polar and Charged Amino Acid Residues in Transmembrane Helix 14 of Multidrug Resistance Protein 1 (MRP1/ABCC1): IDENTIFICATION OF AN ASPARTATE RESIDUE CRITICAL FOR CONVERSION FROM A HIGH TO LOW AFFINITY SUBSTRATE BINDING STATE
J. Biol. Chem., November 14, 2003; 278(46): 46052 - 46063.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
L. F. Payen, M. Gao, C. J. Westlake, S. P. C. Cole, and R. G. Deeley
Role of Carboxylate Residues Adjacent to the Conserved Core Walker B Motifs in the Catalytic Cycle of Multidrug Resistance Protein 1 (ABCC1)
J. Biol. Chem., October 3, 2003; 278(40): 38537 - 38547.
[Abstract] [Full Text] [PDF]

Home page
 Drug Metab. Dispos.Home page
K. Nunoya, C. E. Grant, D. Zhang, S. P. C. Cole, and R. G. Deeley
MOLECULAR CLONING AND PHARMACOLOGICAL CHARACTERIZATION OF RAT MULTIDRUG RESISTANCE PROTEIN 1 (MRP1)
Drug Metab. Dispos., August 1, 2003; 31(8): 1016 - 1026.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
N. Zelcer, M. T. Huisman, G. Reid, P. Wielinga, P. Breedveld, A. Kuil, P. Knipscheer, J. H. M. Schellens, A. H. Schinkel, and P. Borst
Evidence for Two Interacting Ligand Binding Sites in Human Multidrug Resistance Protein 2 (ATP Binding Cassette C2)
J. Biol. Chem., June 20, 2003; 278(26): 23538 - 23544.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
T. Konno, T. Ebihara, K. Hisaeda, T. Uchiumi, T. Nakamura, T. Shirakusa, M. Kuwano, and M. Wada
Identification of Domains Participating in the Substrate Specificity and Subcellular Localization of the Multidrug Resistance Proteins MRP1 and MRP2
J. Biol. Chem., June 13, 2003; 278(25): 22908 - 22917.
[Abstract] [Full Text] [PDF]

Home page
 J. Pharmacol. Exp. Ther.Home page
E. M. Leslie, R. J. Bowers, R. G. Deeley, and S. P. C. Cole
Structural Requirements for Functional Interaction of Glutathione Tripeptide Analogs with the Human Multidrug Resistance Protein 1 (MRP1)
J. Pharmacol. Exp. Ther., February 1, 2003; 304(2): 643 - 653.
[Abstract] [Full Text] [PDF]

Home page
 Drug Metab. Dispos.Home page
E. M. Leslie, R. G. Deeley, and S. P. C. Cole
Bioflavonoid Stimulation of Glutathione Transport by the 190-kDa Multidrug Resistance Protein 1 (MRP1)
Drug Metab. Dispos., January 1, 2003; 31(1): 11 - 15.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
K. Koike, C. J. Oleschuk, A. Haimeur, S. L. Olsen, R. G. Deeley, and S. P. C. Cole
Multiple Membrane-associated Tryptophan Residues Contribute to the Transport Activity and Substrate Specificity of the Human Multidrug Resistance Protein, MRP1
J. Biol. Chem., December 13, 2002; 277(51): 49495 - 49503.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Pharmacol.Home page
D. Burg, P. Wielinga, N. Zelcer, T. Saeki, G. J. Mulder, and P. Borst
Inhibition of the Multidrug Resistance Protein 1 (MRP1) by Peptidomimetic Glutathione-Conjugate Analogs
Mol. Pharmacol., November 1, 2002; 62(5): 1160 - 1166.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
A. Haimeur, R. G. Deeley, and S. P. C. Cole
Charged Amino Acids in the Sixth Transmembrane Helix of Multidrug Resistance Protein 1 (MRP1/ABCC1) Are Critical Determinants of Transport Activity
J. Biol. Chem., October 25, 2002; 277(44): 41326 - 41333.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
Y.-M. Qian, C. E. Grant, C. J. Westlake, D.-W. Zhang, P. A. Lander, R. L. Shepard, A. H. Dantzig, S. P. C. Cole, and R. G. Deeley
Photolabeling of Human and Murine Multidrug Resistance Protein 1 with the High Affinity Inhibitor [125I]LY475776 and Azidophenacyl-[35S]Glutathione
J. Biol. Chem., September 13, 2002; 277(38): 35225 - 35231.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
Q. Mao, W. Qiu, K. E. Weigl, P. A. Lander, L. B. Tabas, R. L. Shepard, A. H. Dantzig, R. G. Deeley, and S. P. C. Cole
GSH-dependent Photolabeling of Multidrug Resistance Protein MRP1 (ABCC1) by [125I]LY475776. EVIDENCE OF A MAJOR BINDING SITE IN THE COOH-PROXIMAL MEMBRANE SPANNING DOMAIN
J. Biol. Chem., August 2, 2002; 277(32): 28690 - 28699.
[Abstract] [Full Text] [PDF]

Home page
 J. Pharmacol. Exp. Ther.Home page
P. M. Gerk and M. Vore
Regulation of Expression of the Multidrug Resistance-Associated Protein 2 (MRP2) and Its Role in Drug Disposition
J. Pharmacol. Exp. Ther., August 1, 2002; 302(2): 407 - 415.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
Y.-M. Qian, W. Qiu, M. Gao, C. J. Westlake, S. P. C. Cole, and R. G. Deeley
Characterization of Binding of Leukotriene C4 by Human Multidrug Resistance Protein 1. EVIDENCE OF DIFFERENTIAL INTERACTIONS WITH NH2- AND COOH-PROXIMAL HALVES OF THE PROTEIN
J. Biol. Chem., October 12, 2001; 276(42): 38636 - 38644.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
D.-W. Zhang, S. P. C. Cole, and R. G. Deeley
Identification of a Nonconserved Amino Acid Residue in Multidrug Resistance Protein 1 Important for Determining Substrate Specificity. EVIDENCE FOR FUNCTIONAL INTERACTION BETWEEN TRANSMEMBRANE HELICES 14 AND 17
J. Biol. Chem., September 7, 2001; 276(37): 34966 - 34974.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
K.-i. Ito, C. J. Oleschuk, C. Westlake, M. Z. Vasa, R. G. Deeley, and S. P. C. Cole
Mutation of Trp1254 in the Multispecific Organic Anion Transporter, Multidrug Resistance Protein 2 (MRP2) (ABCC2), Alters Substrate Specificity and Results in Loss of Methotrexate Transport Activity
J. Biol. Chem., October 5, 2001; 276(41): 38108 - 38114.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2001 by the American Society for Biochemistry and Molecular Biology.
Advertisement
spacer
Advertisement
Advertisement